Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Cellular Biomedicine Group Inc. (CBMG)

18.26   0.25 (1.39%) 03-20 15:56
Open: 18 Pre. Close: 18.01
High: 18.56 Low: 17.68
Volume: 28,778 Market Cap: 330M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 18.241 - 18.328 18.328 - 18.407
Low: 16.892 - 16.99 16.99 - 17.079
Close: 17.843 - 18.01 18.01 - 18.161

Technical analysis

as of: 2019-03-20 3:23:28 PM
Overall:       
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 23.64     One year: 27.61
Support: Support1: 17.56    Support2: 15.90
Resistance: Resistance1: 20.24    Resistance2: 23.64
Pivot: 18.42
Moving Average: MA(5): 17.38     MA(20): 18.39
MA(100): 17.76     MA(250): 18.65
MACD: MACD(12,26): -0.17     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 50.51     %D(3): 32.11
RSI: RSI(14): 50.71
52-week: High: 25.00  Low: 12.04  Change(%): -4.0
Average Vol(K): 3-Month: 5952  10-Days: 5766

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CBMG has closed above bottom band by 47.6%. Bollinger Bands are 10.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 20 Feb 2019 16:17:05 Z
Cellular Biomedicine Group (CBMG) Reports Q4 Loss, Lags Revenue Estimates

Tue, 06 Nov 2018 15:56:24 Z
Cellular Biomedicine Group (CBMG) Reports Q3 Loss, Tops Revenue Estimates

Thu, 01 Nov 2018 17:15:55 Z
Earnings Preview: Cellular Biomedicine Group (CBMG) Q3 Earnings Expected to Decline

Tue, 02 Jan 2018 21:08:41 Z
Tuesday Sector Leaders: Non-Precious Metals & Non-Metallic Mining, Biotechnology Stocks

Thu, 28 Dec 2017 21:27:09 Z
Health Care Sector Update for 12/28/2017: VTVT,CBMG,ACST,ACST.V

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 18.08
Shares Float (M)
% Held by Insiders
% Held by Institutions 14.80
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -2.050
EPS Est. Current Year -1.560
EPS Est. Next Year -1.550
EPS Est. Next Quarter -0.400
Forward EPS -1.830
Book Value (p.s.) 3.640
PEG Ratio
Profit Margin
Operating Margin -16751.75
Return on Assets (ttm) -51.0
Return on Equity (ttm) -54.7
Qtrly Rev. Growth -62.6
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -25.11
Levered Free Cash Flow (M) -17.48

Stock Valuations

P/E -8.94
P/E Growth Ratio 0.02
P/BV 5.04
P/S 33140639744.00
P/CF -13.20

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2013-01-31
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.